Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Cuproptosis: mechanisms and links with cancers
J **e, Y Yang, Y Gao, J He - Molecular cancer, 2023 - Springer
Cuproptosis was a copper-dependent and unique kind of cell death that was separate from
existing other forms of cell death. The last decade has witnessed a considerable increase in …
existing other forms of cell death. The last decade has witnessed a considerable increase in …
Signal pathways of melanoma and targeted therapy
W Guo, H Wang, C Li - Signal transduction and targeted therapy, 2021 - nature.com
Melanoma is the most lethal skin cancer that originates from the malignant transformation of
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …
[HTML][HTML] Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Platinum-based chemotherapy is the standard first-line treatment for advanced esophageal
squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial. gov: NCT03829969) …
squamous cell carcinoma (ESCC). In this phase 3 study (ClinicalTrial. gov: NCT03829969) …
[HTML][HTML] Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer
L Yang, HJ **e, YY Li, X Wang, XX Liu… - Oncology …, 2022 - spandidos-publications.com
Cisplatin is one of the most effective chemotherapy drugs for ovarian cancer, but resistance
is common. The initial response to platinum‑based chemotherapy is as high as 80%, but in …
is common. The initial response to platinum‑based chemotherapy is as high as 80%, but in …
[HTML][HTML] Application of PD-1 blockade in cancer immunotherapy
X Wu, Z Gu, Y Chen, B Chen, W Chen, L Weng… - Computational and …, 2019 - Elsevier
The programmed cell death protein 1 (PD-1) pathway has received considerable attention
due to its role in eliciting the immune checkpoint response of T cells, resulting in tumor cells …
due to its role in eliciting the immune checkpoint response of T cells, resulting in tumor cells …
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
M Marzagalli, ND Ebelt, ER Manuel - Seminars in cancer biology, 2019 - Elsevier
Cutaneous melanoma is the most common skin cancer with an incidence that has been
rapidly increasing in the past decades. Melanomas are among the most immunogenic …
rapidly increasing in the past decades. Melanomas are among the most immunogenic …
Immunotherapy for colorectal cancer: rational strategies and novel therapeutic progress
There are increasing incidences and mortality rates for colorectal cancer in the world. It is
common for chemotherapy and radiation given to patients with colorectal cancer to cause …
common for chemotherapy and radiation given to patients with colorectal cancer to cause …
[HTML][HTML] Antitumor effects of immunity-enhancing traditional Chinese medicine
Y Wang, Q Zhang, Y Chen, CL Liang, H Liu… - Biomedicine & …, 2020 - Elsevier
Abstract Traditional Chinese Medicine (TCM) has been traditionally used to treat patients
with cancers in China. It not only alleviates the symptoms of tumor patients and improves …
with cancers in China. It not only alleviates the symptoms of tumor patients and improves …
The role of PD-1/PD-L1 axis in treg development and function: implications for cancer immunotherapy
J Cai, D Wang, G Zhang, X Guo - OncoTargets and therapy, 2019 - Taylor & Francis
During the past decade, immunotherapy targeting immune checkpoints has become an
important component of the treatment paradigm for numerous malignancies, especially PD …
important component of the treatment paradigm for numerous malignancies, especially PD …
Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
S Loizides, A Constantinidou - Frontiers in genetics, 2023 - frontiersin.org
Triple negative breast cancer (TNBC) is a biologically diverse subtype of breast cancer
characterized by genomic and transcriptional heterogeneity and exhibiting aggressive …
characterized by genomic and transcriptional heterogeneity and exhibiting aggressive …